Alkylverdazyls as a Source of Alkyl Radicals for Light-Triggered Cancer Cell Death.
alkylated verdazyls
cancer cell death
photolysis
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
03 01 2022
03 01 2022
Historique:
pubmed:
11
12
2021
medline:
29
3
2022
entrez:
10
12
2021
Statut:
ppublish
Résumé
Two alkylated verdazyl radicals (AlkVZs) were investigated as active compounds for photoinitiated controlled MCF-7 cell death. Observed results unambiguously showed that AlkVZ could be a potential structural moiety for the design of a novel family of photodynamic therapy agents. The main advantage of the proposed substances is an oxygen-independent generation of active radicals, which play a pivotal role in the treatment of oxygen-deficient tumors.
Identifiants
pubmed: 34889598
doi: 10.1021/acs.molpharmaceut.1c00780
doi:
Substances chimiques
Free Radicals
0
Photosensitizing Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM